Abselion

Abselion develops automated analytical instrumentation for biomolecule quantification in biopharmaceutical research and manufacturing.

Its technology enables rapid quantification of antibodies, AAVs and other proteins directly from crude samples without optics or fluidics.

The platform is designed for at-line use in process development and production workflows, with applications spanning antibody development, viral vector characterisation and biologics quality control. Abselion is a spin-out from the University of Cambridge.